Skip to main content
Contact us

Recombinant Proteins CDMO Companies
Proteins Contract Manufacturing

Your Trusted Partners for Proteins Contract Manufacturing and Development

Showing 23 facilities
HIPRA BIOTECH SERVICES | Amer
Spain

HIPRA BIOTECH SERVICES | Amer

HIPRA Biotech Services

End-to-end internal capabilities from cell line development to commercial manufacturing.

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BSL (Biological Safety Level): 1, 2

USE: Human, Veterinary

BATCH SIZE: Large, Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 2 (PDE = 1,000 - 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS, BIOLOGICS

REGION: Europe

JAFRAL
Slovenia

JAFRAL

JAFRAL

Integrated biotechnology facility providing R&D, non-GMP and GMP manufacturing, QC testing, and fill & finish services for advanced biologics.

SERVICES: Development services, Logistics, Analytical / QC services, Packaging, Regulatory services, Quality Assurance services, Manufacturing services

COMPLIANCE: ICH, FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP), SQF (Safe Quality Food)

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia)

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: COSMETICS, NUTRACEUTICALS, FDF / DRUG PRODUCTS, SERVICES, BIOLOGICS

USE: Human, Veterinary

BATCH SIZE: Large, Small, Medium

CONTROLLED SUBSTANCES: Lowest potential for abuse

THERAPEUTIC AREAS OF EXPERTISE (ATC): (J) Antiinfectives for systemic use, (D) Dermatologicals, (V06) Nutrients, (R) Respiratory system, (A) Digestive tract and metabolism

REGION: Europe

53Biologics Production Plant
Spain

53Biologics Production Plant

53Biologics

53Biologics is a Spanish CDMO specialized in decoding the production of biologicals, from DNA to proteins.

MARKETS: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: BIOLOGICS

BDI biotech Production Plant
Spain

BDI biotech Production Plant

BDI biotech

We work as an R&D department specialized in strain and bioprocess development, scale-up and batches production.

MARKETS: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Regulatory services

REGION: Europe

COMPLIANCE: ISO

BSL (Biological Safety Level): 1

BATCH SIZE: Small, Medium

CATEGORY / PRODUCT: BIOLOGICS

Cultiply
Spain

Cultiply

Cultiply

Spanish CDMO that develops production and purification processes for recombinant proteins, enzymes, DNA and other bioderived products.

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), CDSCO (India), TGA (Australia)

REGION: Europe

COMPLIANCE: ISO

BSL (Biological Safety Level): 1, 2

SERVICES: Development services, Manufacturing services

CONTROLLED SUBSTANCES: Lowest potential for abuse

BATCH SIZE: Small, Medium

CATEGORY / PRODUCT: BIOLOGICS

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

Rodon Biologics
Portugal

Rodon Biologics

Rodon Biologics - RDN Serviços de Biotecnologia

Rodon Biologics provides excellence in the development of biopharmaceutical products for third parties.

REGION: Europe

CATEGORY / PRODUCT: NUTRACEUTICALS, BIOLOGICS, SERVICES

BSL (Biological Safety Level): 1, 2

SERVICES: Development services, Analytical / QC services

BATCH SIZE: Small

HIPRA BIOTECH SERVICES | Aiguaviva
Spain

HIPRA BIOTECH SERVICES | Aiguaviva

HIPRA Biotech Services

End-to-end internal capabilities from cell line development to commercial manufacturing.

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BATCH SIZE: Large, Small, Medium

USE: Human

BSL (Biological Safety Level): 1, 2

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: BIOLOGICS

CZ Vaccines | Large Scale Plant Portugal
Portugal

CZ Vaccines | Large Scale Plant Portugal

CZ Vaccines

Commercial Scale Facility

MARKETS: EMA (EU)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

BATCH SIZE: Large, Medium

USE: Human

BSL (Biological Safety Level): 1, 2

THERAPEUTIC AREAS OF EXPERTISE (ATC): (J) Antiinfectives for systemic use, (R) Respiratory system, (G) Genito urinary system and sex hormones

CATEGORY / PRODUCT: BIOLOGICS, FDF / DRUG PRODUCTS

MARKETS: EMA (EU), ANVISA (Brazil), CDSCO (India)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: ISO, ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)

USE: Human

BSL (Biological Safety Level): 1, 2

THERAPEUTIC AREAS OF EXPERTISE (ATC): (R) Respiratory system, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

BATCH SIZE: Small

CATEGORY / PRODUCT: BIOLOGICS, FDF / DRUG PRODUCTS

CZ Vaccines | Large Scale Plant Spain
Spain

CZ Vaccines | Large Scale Plant Spain

CZ Vaccines

Single Use Commercial Scale Facility

MARKETS: EMA (EU)

SERVICES: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

BATCH SIZE: Large, Medium

USE: Human

BSL (Biological Safety Level): 1, 2

THERAPEUTIC AREAS OF EXPERTISE (ATC): (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (G) Genito urinary system and sex hormones

CATEGORY / PRODUCT: BIOLOGICS, FDF / DRUG PRODUCTS

Limited view

BIOLOGICS manufacturing site

MAI network supplier

GMP-compliant biologics manufacturing facility specializing in recombinant enzymes and proteins.

Location available after registration

Limited view

BIOLOGICS manufacturing site

MAI network supplier

Contract Development and Manufacturing Organization (CDMO) with a focus on recombinant proteins and monoclonal antibodies (mAbs).

Location available after registration

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+10 more facilities

Create free account

Recombinant proteins are the foundation of many modern therapies, from vaccines and hormones to enzymes and growth factors. Their complexity, sensitivity, and regulatory demands require specialized infrastructure and know-how, which is why pharmaceutical and biotech companies rely on recombinant proteins CDMO companies to bring these products to life.

By partnering with experts in proteins contract manufacturing, companies benefit from tailored development processes, high-yield expression systems, and robust GMP operations that ensure quality, scalability, and compliance from early development through commercial launch.

How to Choose CDMO Companies for Recombinant Proteins Manufacturing

When evaluating recombinant proteins CDMOs, key factors to consider include:

  • Expression system flexibility: Does the CDMO offer microbial (E. coli, yeast) and mammalian (CHO, HEK293) platforms?
  • Process development expertise: Ability to optimize upstream and downstream workflows for purity, activity, and yield.
  • Scalability: Can they support transitions from lab-scale to pilot and commercial GMP production?
  • Analytical depth: Do they provide comprehensive characterization (e.g., identity, potency, glycosylation, stability)?
  • Regulatory experience: Have they successfully supported INDs, BLAs, or EMA filings involving recombinant proteins?

Choosing a partner with demonstrated protein expertise shortens timelines and mitigates risks in both development and manufacturing.

Key Services Offered by Proteins Contract Manufacturers

Top-tier recombinant proteins contract manufacturing providers offer a comprehensive set of services:

  • Cell line development: Vector design for protein expression.
  • Upstream process optimization: Including fermentation and cell culture.
  • Protein purification: Using affinity, ion-exchange, and size-exclusion chromatography.
  • Refolding and formulation: Of complex or sensitive proteins.
  • Analytical development: HPLC, SDS-PAGE, Western blot, ELISA, and bioassays.
  • GMP manufacturing: For clinical and commercial batches.
  • CMC documentation: And global regulatory support.

These services ensure your recombinant protein is correctly folded, active, stable, and compliant with all regulatory expectations.

Advantages of Partnering with Recombinant Proteins CDMO Companies

Engaging expert recombinant proteins CDMO companies delivers several benefits:

  • Faster development: Using pre-optimized platforms and scalable technologies.
  • High product quality: Through validated purification and analytics.
  • Tailored solutions: For soluble proteins, membrane proteins, and biologics with complex structures.
  • Regulatory readiness: With full CMC support and audit-proven facilities.
  • Integrated workflows: That span from gene synthesis to final GMP release.

The right CDMO partner allows you to focus on science while they handle the complexity of manufacturing.

Recombinant Proteins CDMO Companies

Some of the top recombinant proteins CDMO companies include:

  • 53Biologics: CDMO specialized in decoding biologics production, from DNA to proteins, providing services from preclinical to cGMP manufacturing. [See CDMO profile]
  • Mabion: Fully integrated CDMO offering a wide range of services for the development and GMP manufacturing of biotherapeutics, including monoclonal antibodies and other recombinant protein-based products. [See CDMO profile]
  • Shilpa Biologicals: CDMO supporting process development, from gene to cell line development to GMP, formulation development, analytical development, drug substance, drug product, fill-finish, and packaging. [See CDMO profile]
  • HIPRA BIOTECH SERVICES: End-to-end capabilities from cell line development to commercial manufacturing. [See CDMO profile]
  • Cultiply: Spanish CDMO developing production and purification processes for recombinant proteins, enzymes, DNA, and other bioderived products. [See CDMO profile]
  • SINOWAY INDUSTRIAL CO: One-stop CDMO solutions for Abs (Antibodies), ADC & NDC (Antibody-drug), manufacturing for API and key intermediates. [See CDMO profile]
  • Rodon Biologics: Provides excellence in the development of biopharmaceutical products including Abs (Antibodies), peptides, proteins, and hormones. [See CDMO profile]
  • CZ Vaccines: Single-use commercial scale facility. [See CDMO profile]
  • BDI Biotech Production Plant: R&D department specialized in strain and bioprocess development, scale-up, and batch production. [See CDMO profile]
  • Cambrex Wiesbaden: Expertise in enzyme screening and development of over 800 proprietary enzymes across multiple classes. [See CDMO profile]
  • Adragos Pharma: Specializes in aseptic manufacturing of lyophilized or liquid sterile (bio)pharmaceutical drug products through fill and finish. [See CDMO profile]
  • Kemwell Biopharma Pvt Ltd: Biologics-focused Contract Development and Manufacturing (CDMO) company providing integrated development and manufacturing services to global biopharmaceutical organisations. [See CDMO profile]
  • Demo facility: Tissue therapy, Cell therapy and GTMP (Gene Therapy). [See CDMO profile]

Related Information

Let MAI CDMO Network Help You Find the Right Recombinant Proteins CDMO Partner

At MAI CDMO Network, we specialize in connecting you with qualified recombinant proteins CDMO companies that align with your product goals, expression system, and regulatory path. Whether you need microbial expression, CHO-based production, or full GMP support, we can match you with a trusted proteins contract manufacturing partner.

Start your journey to reliable recombinant protein production today. Contact us and find your ideal CDMO.